bimagrumab glp-1 Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during receptor agonism Lilly stops trial of muscle-sparing
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21























